Centro de Documentacion de Fundación MAPFRE - Benchmark dose risks assesment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses

MAP20071504061

Benchmark dose risks assesment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses / Schlosser, Paul M., ... [et al]

This article presents the later approach, the purpose of which is to combine BMD and pharmacokinetic modeling to estimate human cancer risks from formaldehyde exposure

En: Risk analysis : an international journal. - New York and London : Society for Risk Analysis. - Vol. 23, nº 3, June, 2003 ; p. 473-487

1. Riesgos higiénicos industriales . 2. Cáncer . 3. Toxicología laboral . 4. Formaldehido . 5. Enfermedades profesionales . 6. Evaluación de riesgos . 7. Higiene industrial . I. Scholosser, Paul M. . II. Título.